Meera Oza, MD
Rheumatology · Orange Park, FLNPI 1740203934
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 497 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,458 and has fallen 89.8% since, to $252 in 2025.
Across 497 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$1K
- Novartis$1K
- Johnson & Johnson$961
- UCB, Inc.$943
- GSK$573
- plus $3K from 19 others
Across 6 payments — averaging $5093.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$26K
- Pfizer$4K
What the payments were for
- Grants$2403%
- Food & beverage$8,58196%
- Education$1422%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 79 | $1,341 |
| AbbVie | 68 | $1,323 |
| Novartis | 81 | $1,268 |
| Johnson & Johnson(2 entities) | 45 | $961 |
| UCB, Inc. | 46 | $943 |
| GSK | 35 | $573 |
| AstraZeneca(2 entities) | 24 | $510 |
| Pfizer | 29 | $339 |
| Radius Health, Inc. | 13 | $289 |
| E.r. Squibb & Sons, L.L.C. | 15 | $289 |
| Genentech USA, Inc. | 12 | $209 |
| Sanofi | 8 | $191 |
| Boehringer Ingelheim | 9 | $183 |
| Bristol Myers Squibb | 11 | $124 |
| Octapharma USA, Inc. | 3 | $84 |
| Lilly USA, LLC | 6 | $75 |
| ANI Pharmaceuticals, Inc. | 3 | $73 |
| Aurinia Pharma U.S., Inc. | 2 | $41 |
| Sobi, Inc | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Organon | 1 | $24 |
| Zimmer Biomet | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
| Medexus Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$240
How this compares
$8,963 in reported general payments places this provider in the 55th percentile of 453 rheumatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Leflunomide | 140 | $4,773 |
| Hydroxychloroquine Sulfate | 118 | $3,190 |
| Doxycycline Hyclate | 59 | $2,173 |
| MethotrexateMethotrexate Sodium | 104 | $1,941 |
| Sulfasalazine | 123 | $1,390 |
| Prednisone | 210 | $1,291 |
| Pilocarpine Hcl | 11 | $698 |
| Methylprednisolone | 62 | $610 |
| Alendronate Sodium | 44 | $387 |
| Tizanidine Hcl | 43 | $325 |
| Gabapentin | 45 | $207 |
| Folic Acid | 15 | $132 |
| Allopurinol | 12 | $100 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Orange Park
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Jigar ShahMargate$750K
- Rachel TateHollywood$729K
- Howard BuschLoxahatchee$717K
- Michael WeitzMiami$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.